CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
China Resources Double-Crane Pharmaceutical Company Limited Company Snapshot
China Resources Double-Crane Pharmaceutical Company Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares China Resources Double-Crane Pharmaceutical Company Limited with three other companies in this sector in China: Zhejiang NHU Co.,Ltd (2015 sales of 3.82 billion Chinese Renmimbi [US$550.23 million] of which 95% was Pharmaceutical Chemicals), Apeloa Pharmaceutical Co Ltd (4.34 billion Chinese Renmimbi [US$625.12 million] of which 100% was Health Care & Pharmaceutical), and Shandong Xinhua Pharmaceutical Company Limited (3.60 billion Chinese Renmimbi [US$518.38 million] of which 46% was Preparations).

Sales Analysis. During the year ended December of 2015, sales at China Resources Double-Crane Pharmaceutical Company Limited were 5.14 billion Chinese Renmimbi (US$740.31 million). This is an increase of 20.1% versus 2014, when the company's sales were 4.28 billion Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2013, when China Resources Double-Crane Pharmaceutical Company Limited reported sales of 6.83 billion Chinese Renmimbi. The sales level in 2015 was fairly close to the level five years ago: in 2010, China Resources Double-Crane Pharmaceutical Company Limited had sales of 5.36 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
China Resources Double-Crane Pharmaceutical Company Limited
  Stock Performance Chart for China Resources Double-Crane Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 23.33
(Figures in Chinese Renmimbi)
1 Week -0.3%   13 Weeks 5.3%  
4 Weeks 10.8%   52 Weeks 27.4%  
 
China Resources Double-Crane Pharmaceutical Company Limited Key Data:
  Ticker: 600062 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 5,136,437,537
(Year Ending Jan 2016).
Employees: 14,843
  Currency: Chinese Renmimbi Market Cap: 16,901,899,821
  Fiscal Yr Ends: December Shares Outstanding: 724,470,631
  Share Type: A Gu Closely Held Shares: 470,426,787
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.